Biocon Q4 profit drops 57%, but biosimilars business shines
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
Dr. Aditya Manke — Expert Robotic & Laparoscopic Cancer Surgeon. Precise care, faster recovery.
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
Advanced Robotic & Laparoscopic Cancer Surgery by Dr. Aditya Manke — expert care with faster, safer recovery. Specialist in GI, HPB, and complex cancer surgeries, delivering precision treatment with c
Know more